258 related articles for article (PubMed ID: 9168257)
1. Hydrogen peroxide supports human and rat cytochrome P450 1A2-catalyzed 2-amino-3-methylimidazo[4,5-f]quinoline bioactivation to mutagenic metabolites: significance of cytochrome P450 peroxygenase.
Anari MR; Josephy PD; Henry T; O'Brien PJ
Chem Res Toxicol; 1997 May; 10(5):582-8. PubMed ID: 9168257
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 dependent xenobiotic activation by physiological hydroperoxides in intact hepatocytes.
Anari MR; Khan S; Jatoe SD; O'Brien PJ
Eur J Drug Metab Pharmacokinet; 1997; 22(4):305-10. PubMed ID: 9512925
[TBL] [Abstract][Full Text] [Related]
3. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Sadrieh N; Snyderwine EG
Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
[TBL] [Abstract][Full Text] [Related]
4. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
Edenharder R; Rauscher R; Platt KL
Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
[TBL] [Abstract][Full Text] [Related]
5. Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4, 5-f]quinoline, mediated by cDNA-expressed human CYP1A2.
Miranda CL; Yang YH; Henderson MC; Stevens JF; Santana-Rios G; Deinzer ML; Buhler DR
Drug Metab Dispos; 2000 Nov; 28(11):1297-302. PubMed ID: 11038156
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the mutagenic effects of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) in bacteria with rat-liver 9000 x g supernatant or monolayers of rat hepatocytes as an activation system.
Holme JA; Brunborg G; Alexander J; Trygg B; Bjørnstad C
Mutat Res; 1988 Jan; 197(1):39-49. PubMed ID: 3275882
[TBL] [Abstract][Full Text] [Related]
7. Use of genetically engineered Salmonella typhimurium OY1002/1A2 strain coexpressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase and bacterial O-acetyltransferase in SOS/umu assay.
Aryal P; Terashita T; Guengerich FP; Shimada T; Oda Y
Environ Mol Mutagen; 2000; 36(2):121-6. PubMed ID: 11013410
[TBL] [Abstract][Full Text] [Related]
8. Activation of 6-aminochrysene to genotoxic products by different forms of rat liver cytochrome P450 in an O-acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009).
Yamazaki H; Shimada T
Biochem Pharmacol; 1992 Sep; 44(5):913-20. PubMed ID: 1530660
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Escherichia coli DJ4309 expressing human P450 1A2 in mutagenicity testing of complex food mixtures.
Constable A; Varga N; Josephy PD; Guy P; Turesky RJ
Mutat Res; 1999 Jun; 442(2):79-87. PubMed ID: 10393276
[TBL] [Abstract][Full Text] [Related]
10. Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes.
Yamazaki H; Mimura M; Oda Y; Inui Y; Shiraga T; Iwasaki K; Guengerich FP; Shimada T
Carcinogenesis; 1993 Jul; 14(7):1271-8. PubMed ID: 8330339
[TBL] [Abstract][Full Text] [Related]
11. Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs.
Yamada K; Hakura A; Kato TA; Mizutani T; Saeki K
Mutat Res; 2005 Sep; 586(1):87-95. PubMed ID: 16087391
[TBL] [Abstract][Full Text] [Related]
12. Microsomal activation of 2-amino-3-methylimidazo[4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate.
Yamazoe Y; Shimada M; Kamataki T; Kato R
Cancer Res; 1983 Dec; 43(12 Pt 1):5768-74. PubMed ID: 6416669
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines.
Hellmold H; Overvik E; Strömstedt M; Gustafsson JA
Carcinogenesis; 1993 Sep; 14(9):1751-7. PubMed ID: 8403195
[TBL] [Abstract][Full Text] [Related]
14. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.
Edwards RJ; Murray BP; Murray S; Schulz T; Neubert D; Gant TW; Thorgeirsson SS; Boobis AR; Davies DS
Carcinogenesis; 1994 May; 15(5):829-36. PubMed ID: 8200083
[TBL] [Abstract][Full Text] [Related]
15. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2.
Turesky RJ; Constable A; Richoz J; Varga N; Markovic J; Martin MV; Guengerich FP
Chem Res Toxicol; 1998 Aug; 11(8):925-36. PubMed ID: 9705755
[TBL] [Abstract][Full Text] [Related]
16. Identification of new 2-amino-3-methylimidazo[4,5-f]quinoline urinary metabolites from beta-naphthoflavone-treated mice.
Lakshmi VM; Hsu FF; Zenser TV
Drug Metab Dispos; 2009 Aug; 37(8):1690-7. PubMed ID: 19451400
[TBL] [Abstract][Full Text] [Related]
17. Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo.
Davis CD; Schut HA; Adamson RH; Thorgeirsson UP; Thorgeirsson SS; Snyderwine EG
Carcinogenesis; 1993 Jan; 14(1):61-5. PubMed ID: 8425272
[TBL] [Abstract][Full Text] [Related]
18. Activation and effects of the food-derived heterocyclic amines in extrahepatic tissues.
Overvik E; Hellmold H; Branting C; Gustafsson JA
Princess Takamatsu Symp; 1995; 23():123-33. PubMed ID: 8844803
[TBL] [Abstract][Full Text] [Related]
19. Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation.
Kim D; Guengerich FP
Biochemistry; 2004 Feb; 43(4):981-8. PubMed ID: 14744142
[TBL] [Abstract][Full Text] [Related]
20. Regioselective differences in C(8)- and N-oxidation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2.
Turesky RJ; Parisod V; Huynh-Ba T; Langouët S; Guengerich FP
Chem Res Toxicol; 2001 Jul; 14(7):901-11. PubMed ID: 11453738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
